Ikarian Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,472
| Closed | -$558K | – | 128 |
|
|
2023
Q2 | $558K | Sell |
5,472
-75,092
| -93% | -$7.66M | 0.09% | 58 |
|
|
2023
Q1 | $7.32M | Buy |
+80,564
| New | +$7.32M | 1.66% | 9 |
|
|
2022
Q4 | – | Sell |
-4,064
| Closed | -$102K | – | 85 |
|
|
2022
Q3 | $102K | Sell |
4,064
-16,741
| -80% | -$420K | 0.02% | 60 |
|
|
2022
Q2 | $632K | Sell |
20,805
-66,100
| -76% | -$2.01M | 0.12% | 59 |
|
|
2022
Q1 | $2.85M | Buy |
+86,905
| New | +$2.85M | 0.37% | 31 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 192 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 203 |
|
|
2021
Q2 | – | Sell |
-600
| Closed | -$60K | – | 246 |
|
|
2021
Q1 | $60K | Buy |
+600
| New | +$60K | ﹤0.01% | 172 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 191 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 161 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 141 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 123 |
|